Shopping Cart
Remove All
Your shopping cart is currently empty
UNC8153 TFA is a selective and potent NSD2 protein degrader with anticancer activity.UNC8153 TFA induces NSD2 degradation in MM.1S multiple myeloma cells and inhibits the proliferation of MM.1S cells.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $66 | - | In Stock | |
| 5 mg | $158 | - | In Stock | |
| 10 mg | $248 | - | In Stock | |
| 25 mg | $397 | - | In Stock | |
| 50 mg | $569 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $246 | - | In Stock |
| Description | UNC8153 TFA is a selective and potent NSD2 protein degrader with anticancer activity.UNC8153 TFA induces NSD2 degradation in MM.1S multiple myeloma cells and inhibits the proliferation of MM.1S cells. |
| Molecular Weight | 697.7 |
| Formula | C35H38F3N5O7 |
| Cas No. | 2929304-61-8 |
| Smiles | O=C(O)C(F)(F)F.O=C(NC1=CC=C(C=C1)C(=O)NCCCCCCN)C2=CC=C(C=C2)CN(C(=O)C3=CC=C4NC(=O)COC4=C3)C5CC5 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMF: 30 mg/mL (43 mM), Sonication is recommended. H2O: 5 mg/mL (7.17 mM), Sonication is recommended. Ethanol: 30 mg/mL (43 mM), Sonication is recommended. DMSO: 30 mg/mL (43 mM), Sonication is recommended. PBS pH 7.2: 5 mg/mL (7.17 mM), Sonication is recommended. |
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (2.87 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. |
Solution Preparation Table | |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.